{"id":"W4409440172","doi":"10.1002/acn3.70051","title":"<scp>ADAPT NXT</scp>: Fixed Cycles or Every‐Other‐Week <scp>IV</scp> Efgartigimod in Generalized Myasthenia Gravis","year":2025,"lang":"en","type":"article","venue":"Annals of Clinical and Translational Neurology","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"Genentech; Grifols; Alnylam Pharmaceuticals; Ipsen; Amicus Therapeutics; UCB Pharma; Regeneron Pharmaceuticals; CSL Behring; Argenx; Biogen; Sanofi; Alexion Pharmaceuticals; Pfizer; Amgen","keywords":"Medicine; Dosing; Regimen; Tolerability; Myasthenia gravis; Adverse effect; Clinical endpoint; Randomized controlled trial; Internal medicine; Anesthesia; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006967584,0.0008684778,0.001171363,0.0002414535,0.0002326487,0.0003351024,0.0005931041,0.0007023508,0.004207657],"category_scores_gemma":[0.0003804463,0.0003589504,0.0004637917,0.0001831461,0.0006945507,0.000374741,0.0002302969,0.001264692,0.0005367218],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000466363,"about_ca_system_score_gemma":0.0006544873,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001184067,"about_ca_topic_score_gemma":0.004549237,"domain_scores_codex":[0.9997979,0.00007395247,0.00001419202,0.00004164344,0.00003598959,0.00003638991],"domain_scores_gemma":[0.9997867,0.00003571988,0.00007498045,0.00001957988,0.00001420224,0.00006894788],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.753714,0.0491824,0.004575806,0.001087086,0.001073305,0.0002098517,0.0001523112,0.001333239,0.07428405,0.0002307755,0.001784391,0.1123728],"study_design_scores_gemma":[0.5137374,0.4678497,0.01357308,0.000027583,0.0002332336,0.0001486389,0.00003425532,0.0006091151,0.002756689,0.00007413403,0.0009348078,0.00002127408],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997335,0.0005150594,0.0001684571,0.00007618631,0.00003424365,0.001079938,0.0001825305,0.00003724558,0.0005712203],"genre_scores_gemma":[0.9949963,0.0005432966,0.0006433755,0.0002614505,0.00007737488,0.001582833,0.0002811022,0.000009684564,0.001604572],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004207657,"threshold_uncertainty_score":0.01407605,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1182694316343914,"score_gpt":0.400465939007174,"score_spread":0.2821965073727826,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}